btsamuelsonmd.bsky.social profile picture

Bethany Samuelson Bannow, MD, MCR (she/her)

@btsamuelsonmd.bsky.social

465 Followers

544 Following

Hematologist researcher and advocate, wife, mom of 2 girls for whom I want to change the world. Passionate about equal care and representation in research opportunities for folks with uteruses and all folks with bleeding disorders.

  1. 🐝 Heard the buzz about the ISTH Pulse Podcast at #ISTH2025? 🎧Our hosts @gbarnesmd.bsky.social and @btsamuelsonmd.bsky.social are here to share why this podcast is making waves in the thrombosis and hemostasis world.

    Watch the video now: www.isthcongressdaily.org/articles/Art...

    Are you tuned in? Hear from the ISTH Pulse Podcast co-hosts Geoffrey Barnes, M.D., and Bethany Samuelson Bannow, M.D., for bi-weekly episodes on the latest topics in thrombosis and hemostasis. With th...

    Tune in: The ISTH Pulse Podcast

    Are you tuned in? Hear from the ISTH Pulse Podcast co-hosts Geoffrey Barnes, M.D., and Bethany Samuelson Bannow, M.D., for bi-weekly episodes on the latest topics in thrombosis and hemostasis. With th...

    0
  2. 📢 New "Clot, Clot" Podcast 🎙️ Episode live from #ISTH2025‼️ A joint effort 🤝from the @isth.org and Vasculearn Network/ @thjournal.bsky.social Thieme

    Listen to @btsamuelsonmd.bsky.social. Erik Klok and @gbarnesmd.bsky.social about how we talk about #anticoagulation🗣️💊

    www.linkedin.com/posts/vascul...

    🎙️ New Episode Alert: “Clot, Clot, Who’s There?”

Anticoagulation therapy is life-saving—but also life-changing. In today’s episode, Dr. Bethany Samuelson Bannow is joined by Dr. Erik Klok and Dr. Geo...

    🎙️ New Episode Alert: “Clot, Clot, Who’s There?” | Vasculearn Network

    🎙️ New Episode Alert: “Clot, Clot, Who’s There?” Anticoagulation therapy is life-saving—but also life-changing. In today’s episode, Dr. Bethany Samuelson Bannow is joined by Dr. Erik Klok and Dr. Geo...

    1
  3. So excited to work with @isth.org on the Pulse Podcast - such a great opportunity for relevant, digestible discussions of important topics on the go!

    0
  4. My Canadian university, Queen's, is offering TWENTY 4-year funded PhDs (40k CAD/yr) for a student of ANY citizenship who has been accepted at a top 100 US university but have had offer rescinded OR are reconsidering offer due to US policy. Details found here👇

    www.queensu.ca/grad-postdoc...

    Queen’s University is a globally engaged, research-intensive institution dedicated to attracting and supporting exceptional PhD students who will significantly advance our research mission.

    Queen’s Special U.S. Doctoral Recruitment Initiative | School of Graduate Studies and Postdoctoral AffairsDown arrowDown arrowDown arrowDown arrowDown arrowDown arrowDown arrowDown arrowDown arrowDown...

    Queen’s University is a globally engaged, research-intensive institution dedicated to attracting and supporting exceptional PhD students who will significantly advance our research mission.

    21
  5. Pregnancy-Related VTE Risk Perception & Prevention in Risk-Averse Times—Significant Change Required vimeo.com/1072760896 @btsamuelsonmd.bsky.social @marccarriermd.bsky.social @isth.org @worldthrombosisday.bsky.social @thrombosisuk.bsky.social @jeanconnorsmd.bsky.social @bsochaem.bsky.social

    Pregnancy-related venous thromboembolism risk perception and prevention in risk-averse times - significant change required; a commentary

    Video abstract - VTE prevention strategy - 20250320

    Pregnancy-related venous thromboembolism risk perception and prevention in risk-averse times - significant change required; a commentary

    0
  6. Super interesting findings! We've been using chromogenic FVIII for awhile in our AFAB folks with FVIII mutations - will you make the switch? www.jthjournal.org/article/S153...

    For every man diagnosed with hemophilia, approximately 1.6 women are expected to be
carriers. Carriers are classified based on their factor (F) VIII levels and symptoms,
ranging from asymptomatic to m...

    Discrepancy between one-stage clotting and chromogenic factor VIII activity in women with hemophilia A and hemophilia A carriers: a retrospective clinical study

    For every man diagnosed with hemophilia, approximately 1.6 women are expected to be carriers. Carriers are classified based on their factor (F) VIII levels and symptoms, ranging from asymptomatic to m...

    0